Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms 18F-FSA |
Target |
Action modulators |
Mechanism APP modulators(Beta amyloid A4 protein modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Clinical | United States | 07 Nov 2023 |